SCHEMBL23660732

SCHEMBL23660732

CC(CNCC(N)=O)NCC(N)=O

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
DPP4 P27487 6/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4343330 0.79
SCHEMBL2423251 0.77
SCHEMBL22221540 0.77
SCHEMBL783333 0.77
SCHEMBL18743786 0.76
SCHEMBL7569975 0.76 ALDH1A1 (0.39) DPP4
SCHEMBL7348552 0.74 ALDH1A1 (0.40) DPP4
SCHEMBL1378572 0.74
SCHEMBL5017599 0.72 KISS1R (0.35) MAOAMAOBDPP4
SCHEMBL20635099 0.72 MAOA (0.35) MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021144746-A1 USE OF ICRF-193 DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF FOR THE PREVENTION OF CHRONIC CUMULATIVE CARDIOTOXICITY CAUSED BY THERAPY WITH ANTHRACYCLINE ANTICANCER DRUGS UNIVERZITA KARLOVA V PRAZE (CZ) 2021-07-22 WO disclosed